Releases
Found 41441 articles
DISA Uranium Launches to Overhaul U.S. Nuclear Fuel Supply
With a US$105 million financing round and a fresh NRC license in hand, Casper-based DISA Uranium is launching a mission to turn the American West's abandoned mine waste into a viable domestic fuel source, while simultaneously acquiring a portfolio of conventional Utah mines from IsoEnergy Ltd.
CGI Federal Secures $251 Million GSA Financial Modernization Contract
The U.S. General Services Administration has awarded CGI Federal a $251 million contract to maintain the Pegasys financial management system and its Multi-Tenant Shared Application environment. The deal focuses on cloud-based modernization, aiming to reduce manual labor and improve processing performance across 36 federal agencies.
Alpha Omega Adds AI-Driven Modernization Tools to Tradewinds Marketplace
Federal agencies now have streamlined access to three AI-powered modernization accelerators through the Department of War’s Tradewinds Solutions Marketplace. By listing its Continuum Automation Framework on this platform, Alpha Omega allows government customers to bypass traditional competitive bidding processes for system design, legacy code refactoring, and data integration.
DISA Tech Spins Off to Scale Mineral Processing Technology
Wyoming-based DISA Technologies has launched DISA Tech as an independent firm, carving out its mineral processing operations from its uranium business. The split creates two distinct entities, allowing the newly formed DISA Tech to focus exclusively on commercializing its patented high-pressure slurry ablation technology across global markets.
PowerBank secures key approvals for Ontario battery storage project
PowerBank Corporation has cleared a major regulatory hurdle for its 903 BESS project in Ontario, securing essential Official Plan and Zoning Bylaw amendments. These approvals conclude the most complex phase of the permitting process, positioning the company to begin construction on the energy storage site by the fourth quarter of 2026.
Galaxy Therapeutics Secures European Approval for SEAL Embolization System
Milpitas-based Galaxy Therapeutics has secured CE Mark certification for its SEAL Embolization System, clearing the way for the company to launch its neurovascular device across the European Economic Area. The regulatory milestone validates the company’s intrasaccular technology for treating both ruptured and unruptured wide-neck intracranial aneurysms.
Microsoft Faces Securities Fraud Lawsuit Over Copilot Performance
A federal class action lawsuit now targets Microsoft and its senior executives, alleging the company misled investors about the stability of its Copilot AI chatbot and the health of its Azure cloud platform. The legal challenge follows a sharp 10% stock decline triggered by disappointing quarterly financial results.
Peabody Energy Faces Class Action Over Centurion Mine Production Failures
A federal securities class action lawsuit has been filed against Peabody Energy, alleging the company misled investors about the operational readiness of its flagship Centurion coal mine. The litigation follows a series of production shortfalls that triggered significant declines in the company’s stock price throughout the first half of 2026.
Investors File Class Action Against PROCEPT BioRobotics Over Sales Claims
A securities fraud class action lawsuit now targets PROCEPT BioRobotics Corporation, alleging the medical technology firm artificially bolstered its financial performance. The complaint claims that an aggressive discount program incentivized bulk orders, misleading investors about the actual demand for the company’s surgical handpieces and causing significant stock price volatility.
Utz Brands Faces Shareholder Investigation Over Intersnack Merger
A 50% ownership stake for the founding Rice and Lissette family following the proposed $14.25 per share acquisition of Utz Brands by Intersnack Group has triggered a formal investigation by the securities law firm Bleichmar Fonti & Auld LLP.
Planet Fitness Faces Class Action After Marketing Pivot Triggers 31% Drop
A federal securities class action lawsuit now targets Planet Fitness following a disastrous marketing shift that alienated the company’s core customer base. The litigation, filed in the District of New Hampshire, centers on allegations that executives misled investors regarding the success of campaigns that ultimately stalled Q1 membership growth.
ZoomInfo Faces Class Action Lawsuit After AI Strategy Backfires
A 33% collapse in ZoomInfo Technologies' stock price has triggered a securities fraud class action, with investors alleging the company misled them about the effectiveness of its AI-integrated products. The lawsuit, filed in the Western District of Washington, centers on claims that management concealed declining customer retention rates.
Capricor Therapeutics Faces Class Action After Deramiocel Data Concerns
A 64.5% single-day stock collapse has triggered a securities fraud class action against Capricor Therapeutics, as investors allege the biotech firm misled the market regarding the integrity of clinical data used in its Biologics License Application for the investigational drug Deramiocel.
Insulet Faces Securities Fraud Lawsuit Over Omnipod Safety Failures
A federal class action lawsuit now targets Insulet Corporation, alleging the company misled investors regarding the safety and manufacturing quality of its Omnipod insulin delivery systems. The litigation follows a series of product corrections that triggered significant stock price declines for the medical device manufacturer earlier this year.
Zillow Faces Securities Class Action Over Redfin Antitrust Allegations
A federal class action lawsuit now targets Zillow Group following a series of stock price collapses linked to an alleged anticompetitive pact with Redfin. Investors claim the company misled them about the nature of a $100 million deal that the Federal Trade Commission describes as an illegal market-exit payment.
Regeneron Faces Class Action Over Alleged Clinical Trial Misstatements
A federal securities fraud lawsuit now targets Regeneron Pharmaceuticals following a sharp decline in share price tied to the failure of its Phase III Fianlimab-Libtayo clinical trial. Investors allege the company misled them about the drug combination's potential as a blockbuster treatment for advanced melanoma before revealing lackluster statistical results.
Intuit Faces Securities Fraud Lawsuit Following 20% Stock Plunge
A federal class action lawsuit now targets Intuit Inc. after the company’s share price cratered by over 20% in May 2026. Investors allege that leadership misled them regarding TurboTax’s competitive standing and growth potential while the firm struggled to maintain its footing among price-sensitive tax filers.
Cogent Communications Faces Class Action Over Wavelength Business Claims
A securities fraud class action has been launched against Cogent Communications Holdings, Inc. and its senior executives following a series of sharp stock declines. The lawsuit, filed in the U.S. District Court for the District of Columbia, alleges the company misled investors regarding customer demand for its wavelength services.
ADMA Biologics Faces Securities Fraud Lawsuit Over Channel Stuffing Claims
Investors have initiated a class action lawsuit against ADMA Biologics, alleging the biopharmaceutical company artificially inflated its 2025 growth figures through a deceptive channel stuffing scheme. The legal action follows a series of sharp stock declines triggered by investigative reports questioning the firm's reported revenue and distributor relationships.
Embecta Investors File Class Action Following 57% Stock Plunge
A 57.8% single-day collapse in Embecta’s stock price has triggered a securities fraud class action lawsuit, with investors alleging the medical device manufacturer misled them regarding the health of its insulin pen needle business while market share was quietly eroding to competitors.
EquipmentShare Faces Class Action Over Undisclosed Founder Payouts
Investors have launched a class action lawsuit against EquipmentShare following a double-digit stock decline triggered by reports that the company’s co-founders pocketed at least $77 million through undisclosed related-party transactions. The legal challenge centers on allegations that the firm misled shareholders during its recent public offering.
Rackspace Faces Securities Fraud Suit After 33% Stock Collapse
A 33.6% plunge in Rackspace Technology stock has triggered a federal class action lawsuit in New York. Investors allege the cloud provider misled them regarding the financial strain caused by its artificial intelligence initiatives, specifically claiming the company concealed how AI investments would cannibalize existing revenue-generating segments.
Jordan Kuwait Bank Secures $100 Million for Second Green Bond
Jordan Kuwait Bank has launched its second green bond, securing a commitment of up to $100 million from the International Finance Corporation. This issuance aims to accelerate Jordan’s transition toward a resilient economy by funneling capital into renewable energy, green construction, and sustainable transport projects across the Kingdom.
Global Surfactants Market Projected to Reach $66.95 Billion by 2031
The global surfactants market is set for steady expansion, with valuations expected to climb from $52.25 billion in 2026 to $66.95 billion by 2031. Driven by a shift toward bio-based formulations and industrial demand, the sector is anticipating a compound annual growth rate of 5.08 percent over the next five years.
Mighty Paw Brings Yak Cheese Treats to Walmart Nationwide
More than 2 million dogs across the country will now find their favorite chews on a new shelf, as Mighty Paw expands its retail footprint to Walmart. The brand is rolling out its signature Yak Cheese Chews and Puffs just ahead of National Dog Month to meet growing demand for minimalist ingredients.
Marathon Petroleum Net Income Surges to $5.1 Billion in Second Quarter
Marathon Petroleum Corporation reported a sharp rise in second-quarter net income, reaching $5.1 billion compared to $1.2 billion during the same period last year. The surge was driven by robust refining margins and strong operational performance across its integrated energy value chain, allowing the company to return $2.8 billion to shareholders.
Brightstar Lottery Profits Rise Amid Global Sales Expansion
Brightstar Lottery PLC reported second-quarter profits of $56 million, marking a significant recovery from the $60 million loss recorded during the same period last year. Driven by steady growth in global same-store sales and disciplined cost management, the company is now positioning itself for an inflection in cash flow.
SOPHiA GENETICS Targets Profitability After Revenue Jump
SOPHiA GENETICS posted a 27% year-over-year revenue increase to $23.3 million for the second quarter of 2026, signaling a push toward operational efficiency. As the company navigates a transition in leadership, it has tightened its spending and secured new partnerships to bolster its path toward adjusted EBITDA breakeven.
HawkEye 360 Sets Q2 2026 Earnings Call for August 13
Investors will get an inside look at the mid-year financial performance of HawkEye 360 on August 13, 2026. The signals intelligence firm confirmed it will release its second-quarter results immediately following the market close, providing a window into the company's recent operational and fiscal trajectory.
MPLX Reports Q2 2026 Earnings as Growth Capital Spending Climbs
MPLX LP reported second-quarter 2026 net income of $1.077 billion, up from $1.048 billion in the same period last year, as the energy partnership ramps up infrastructure investments to meet rising global demand for natural gas and natural gas liquids.